ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules
“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of Salix Pharmaceuticals, Inc. (Salix). Mesalamine Extended-Release Capsules are indicated for the maintenance of remi
Announcement as on 02 November 2022

Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsules
The approved drug is therapeutically equivalent to Salix Pharmaceuticals Inc's reference listed drug (RLD), Apriso extended-release capsules, 0.375 g, it added. The drug has an estimated market size of USD 133 million for the months ended June 2022, Alembi
Announcement as on 02 November 2022

Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated, the company said. As per IQVIA data, Alembic said Gl
Announcement as on 01 November 2022

Alembic Pharma gets USFDA nod for generic injection to treat cancer
The approval granted by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Paclitaxel injection of strengths 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) multiple-dose vials.
Announcement as on 27 October 2022

USFDA issues four observations to Alembic Pharma's Panelav plant
Alembic Pharmaceuticals Ltd on Tuesday said the US health regulator has issued a Form 483 with four procedural observations after inspection of its oncology injectable formulation facility at Panelav in Gujarat. As per the US Food and Drug Administration (
Announcement as on 18 October 2022

Announcements by Alembic Ltd. first page | Next page | Prev page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 77.34
  • 12Day Average: 79.56
  • 20Day Average: 82.96
  • 50Day Average: 90.02
  • 100Day Average: 95.16
  • 150Day Average: 97.7
  • 200Day Average: 101.97

506235 Indicators & signals

Indicator MACD (12,26,9)

79.84, 84.08, -3.91
Indicator MACD is in negative zone

Indicator ADX (14)

45.95, 13.65, 36.86
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
27 Fri Mar 2026 75.53 75.00 to 79.00 -4.74% 1.35 times
25 Wed Mar 2026 79.29 77.40 to 80.00 3.18% 0.63 times
24 Tue Mar 2026 76.85 76.00 to 77.57 2.19% 0.72 times
23 Mon Mar 2026 75.20 75.00 to 78.78 -5.79% 0.74 times
20 Fri Mar 2026 79.82 79.45 to 80.54 1.6% 0.39 times
19 Thu Mar 2026 78.56 78.00 to 81.00 -3.6% 0.61 times
18 Wed Mar 2026 81.49 78.50 to 82.29 2.58% 2.88 times
17 Tue Mar 2026 79.44 78.60 to 81.00 -0.26% 0.71 times
16 Mon Mar 2026 79.65 78.00 to 80.75 -1.73% 1.16 times
13 Fri Mar 2026 81.05 80.55 to 83.76 -2.34% 1.23 times
12 Thu Mar 2026 82.99 82.69 to 84.08 -2.12% 0.93 times
11 Wed Mar 2026 84.79 84.50 to 86.30 -0.04% 0.18 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top